These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 20653770

  • 1. Induction of matrix metalloproteinase-1 by small interfering RNA targeting connective tissue growth factor in dermal fibroblasts from patients with systemic sclerosis.
    Ishibuchi H, Abe M, Yokoyama Y, Ishikawa O.
    Exp Dermatol; 2010 Aug; 19(8):e111-6. PubMed ID: 20653770
    [Abstract] [Full Text] [Related]

  • 2. Effect of small interfering RNA on the expression of connective tissue growth factor and type I and III collagen in skin fibroblasts of patients with systemic sclerosis.
    Xiao R, Liu FY, Luo JY, Yang XJ, Wen HQ, Su YW, Yan KL, Li YP, Liang YS.
    Br J Dermatol; 2006 Dec; 155(6):1145-53. PubMed ID: 17107381
    [Abstract] [Full Text] [Related]

  • 3. Attenuation of collagen production with small interfering RNA of SPARC in cultured fibroblasts from the skin of patients with scleroderma.
    Zhou X, Tan FK, Guo X, Arnett FC.
    Arthritis Rheum; 2006 Aug; 54(8):2626-31. PubMed ID: 16871529
    [Abstract] [Full Text] [Related]

  • 4. Effect of granulocyte macrophage-colony stimulating factor on extracellular matrix deposition by dermal fibroblasts from patients with scleroderma.
    Postiglione L, Ladogana P, Montagnani S, di Spigna G, Castaldo C, Turano M, Bruno EM, Di Meglio F, Riccio A, Rossi G.
    J Rheumatol; 2005 Apr; 32(4):656-64. PubMed ID: 15801021
    [Abstract] [Full Text] [Related]

  • 5. The fibrotic phenotype of systemic sclerosis fibroblasts varies with disease duration and severity of skin involvement: reconstitution of skin fibrosis development using a tissue engineering approach.
    Corriveau MP, Boufaied I, Lessard J, Chabaud S, Senécal JL, Grodzicky T, Chartier S, Raymond Y, Moulin VJ.
    J Pathol; 2009 Mar; 217(4):534-42. PubMed ID: 19086038
    [Abstract] [Full Text] [Related]

  • 6. Selective stimulation of collagen synthesis in the presence of costimulatory insulin signaling by connective tissue growth factor in scleroderma fibroblasts.
    Gore-Hyer E, Pannu J, Smith EA, Grotendorst G, Trojanowska M.
    Arthritis Rheum; 2003 Mar; 48(3):798-806. PubMed ID: 12632435
    [Abstract] [Full Text] [Related]

  • 7. Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a connective tissue growth factor (CCN2)/transforming growth factor β-dependent mesenchymal-to-mesenchymal transition.
    Serratì S, Chillà A, Laurenzana A, Margheri F, Giannoni E, Magnelli L, Chiarugi P, Dotor J, Feijoo E, Bazzichi L, Bombardieri S, Kahaleh B, Fibbi G, Del Rosso M.
    Arthritis Rheum; 2013 Jan; 65(1):258-69. PubMed ID: 22972461
    [Abstract] [Full Text] [Related]

  • 8. Long non-coding RNA TSIX is upregulated in scleroderma dermal fibroblasts and controls collagen mRNA stabilization.
    Wang Z, Jinnin M, Nakamura K, Harada M, Kudo H, Nakayama W, Inoue K, Nakashima T, Honda N, Fukushima S, Ihn H.
    Exp Dermatol; 2016 Feb; 25(2):131-6. PubMed ID: 26566700
    [Abstract] [Full Text] [Related]

  • 9. Attenuation of fibrosis with selective inhibition of c-Abl by siRNA in systemic sclerosis dermal fibroblasts.
    Karimizadeh E, Motamed N, Mahmoudi M, Jafarinejad-Farsangi S, Jamshidi A, Faridani H, Gharibdoost F.
    Arch Dermatol Res; 2015 Mar; 307(2):135-42. PubMed ID: 25527259
    [Abstract] [Full Text] [Related]

  • 10. Down-regulation of collagen and connective tissue growth factor expression with hepatocyte growth factor in lung fibroblasts from white scleroderma patients via two signaling pathways.
    Bogatkevich GS, Ludwicka-Bradley A, Highland KB, Hant F, Nietert PJ, Singleton CB, Silver RM.
    Arthritis Rheum; 2007 Oct; 56(10):3468-77. PubMed ID: 17907155
    [Abstract] [Full Text] [Related]

  • 11. MiR-29a reduces TIMP-1 production by dermal fibroblasts via targeting TGF-β activated kinase 1 binding protein 1, implications for systemic sclerosis.
    Ciechomska M, O'Reilly S, Suwara M, Bogunia-Kubik K, van Laar JM.
    PLoS One; 2014 Oct; 9(12):e115596. PubMed ID: 25549087
    [Abstract] [Full Text] [Related]

  • 12. Modulation of collagen type I, fibronectin and dermal fibroblast function and activity, in systemic sclerosis by the antioxidant epigallocatechin-3-gallate.
    Dooley A, Shi-Wen X, Aden N, Tranah T, Desai N, Denton CP, Abraham DJ, Bruckdorfer R.
    Rheumatology (Oxford); 2010 Nov; 49(11):2024-36. PubMed ID: 20627968
    [Abstract] [Full Text] [Related]

  • 13. microRNA-92a expression in the sera and dermal fibroblasts increases in patients with scleroderma.
    Sing T, Jinnin M, Yamane K, Honda N, Makino K, Kajihara I, Makino T, Sakai K, Masuguchi S, Fukushima S, Ihn H.
    Rheumatology (Oxford); 2012 Sep; 51(9):1550-6. PubMed ID: 22661558
    [Abstract] [Full Text] [Related]

  • 14. Proteasome blockade exerts an antifibrotic activity by coordinately down-regulating type I collagen and tissue inhibitor of metalloproteinase-1 and up-regulating metalloproteinase-1 production in human dermal fibroblasts.
    Fineschi S, Reith W, Guerne PA, Dayer JM, Chizzolini C.
    FASEB J; 2006 Mar; 20(3):562-4. PubMed ID: 16410344
    [Abstract] [Full Text] [Related]

  • 15. Attenuation of expression of extracellular matrix genes with siRNAs to Sparc and Ctgf in skin fibroblasts of CTGF transgenic mice.
    Wang JC, Sonnylal S, Arnett FC, De Crombrugghe B, Zhou X.
    Int J Immunopathol Pharmacol; 2011 Mar; 24(3):595-601. PubMed ID: 21978691
    [Abstract] [Full Text] [Related]

  • 16. COA-Cl prevented TGF-β1-induced CTGF expression by Akt dephosphorylation in normal human dermal fibroblasts, and it attenuated skin fibrosis in mice models of systemic sclerosis.
    Nakai K, Karita S, Igarashi J, Tsukamoto I, Hirano K, Kubota Y.
    J Dermatol Sci; 2019 Apr; 94(1):205-212. PubMed ID: 30954335
    [Abstract] [Full Text] [Related]

  • 17. CD109, a TGF-β co-receptor, attenuates extracellular matrix production in scleroderma skin fibroblasts.
    Man XY, Finnson KW, Baron M, Philip A.
    Arthritis Res Ther; 2012 Jun 13; 14(3):R144. PubMed ID: 22694813
    [Abstract] [Full Text] [Related]

  • 18. Retinoic acids exhibit anti-fibrotic activity through the inhibition of 5-lipoxygenase expression in scleroderma fibroblasts.
    Xiao R, Yoshida N, Higashi Y, Lu QJ, Fukushige T, Kanzaki T, Kanekura T.
    J Dermatol; 2011 Apr 13; 38(4):345-53. PubMed ID: 21352343
    [Abstract] [Full Text] [Related]

  • 19. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
    Chujo S, Shirasaki F, Kawara S, Inagaki Y, Kinbara T, Inaoki M, Takigawa M, Takehara K.
    J Cell Physiol; 2005 May 13; 203(2):447-56. PubMed ID: 15605379
    [Abstract] [Full Text] [Related]

  • 20. SPARC, an upstream regulator of connective tissue growth factor in response to transforming growth factor beta stimulation.
    Zhou XD, Xiong MM, Tan FK, Guo XJ, Arnett FC.
    Arthritis Rheum; 2006 Dec 13; 54(12):3885-9. PubMed ID: 17133596
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.